Graft-versus-host Disease Clinical Trial
Official title:
A Prospective Randomized Study Comparing Rapamune and Tacrolimus vs. Cyclosporine and Methotrexate as Immune Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplantation, Using HLA-A, -B, -DRβ1 Identical Related or Unrelated Donors. A Nordic Multicenter Study.
Verified date | April 2015 |
Source | Karolinska Institutet |
Contact | n/a |
Is FDA regulated | No |
Health authority | Sweden: Regional Ethical Review Board |
Study type | Interventional |
To evaluate if rapamune + tacrolimus immunosuppressive prophylaxis is better than the established therapy using cyclosporine and methotrexate, a Nordic prospective multicenter randomized study will be performed. Patients will be randomized to treatment with rapamune combined with tacrolimus, or the established therapy using cyclosporine and methotrexate.
Status | Completed |
Enrollment | 215 |
Est. completion date | April 2015 |
Est. primary completion date | February 2015 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 6 Months to 75 Years |
Eligibility |
Inclusion Criteria: - Chronic myeloid leukemia (CML) in 1st or 2nd chronic phase, acute myeloid leukemia (AML) in complete remission, acute lymphoblastic leukemia (ALL) in complete remission, myelodysplastic syndrome, chronic lymphocytic leukemia, lymphoma, non-malignant disorders, severe aplastic anemia, hemoglobinopathies and metabolic disorders Exclusion Criteria: - Recipients of major HLA-mismatched grafts. - Patients who are addicted to drugs or alcohol. - Patients who receive other stem cell source than bone marrow or peripheral stem cells, for instance cord blood transplants. - Patients with relapse or blast crisis of their malignant disease. - Prior allogeneic transplant using any hematopoietic stem cell source - Seropositive for the human immunodeficiency virus (HIV) - Uncontrolled bacterial, viral, or fungal infection (progression of clinical symptoms) Pregnant (positive serum human chorionic gonadotropin [ß-HCG] test) or breastfeeding within 4 weeks of study entry - Kidney function: serum creatinine outside the normal range for age, or measured creatinine clearance less than 40 mL/min/1.72m² within 4 weeks of study entry and proteinuria >0.3 g/day - Liver function: most recent direct bilirubin, ALT, or AST greater than two times the upper limit of normal within 4 weeks of study entry - Lung disease: in adults, FVC or FEV1 less than 60% of predicted value (corrected for hemoglobin); in children, overt hypoxemia, as measured by an oxygen saturation of less than 92% within 4 weeks of study entry - Cardiac ejection fraction of less than 45% in adults and children, or less than 26% shortening fraction in children within 4 weeks of study entry - Cholesterol level greater than 300 mg/dL or triglyceride level greater than 300 mg/dL while being treated, or not on appropriate lipid-lowering therapy within 4 weeks of study entry - Karnofsky score <70% - Prior history of allergy to sirolimus - Requires voriconazole at time of study entry - Currently receiving another investigational drug unless cleared by the principal investigator and sponsor - Patients receiving BuCy as conditioning therapy |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention
Country | Name | City | State |
---|---|---|---|
Sweden | Karolinska University Hospital | Stockholm |
Lead Sponsor | Collaborator |
---|---|
Karolinska Institutet |
Sweden,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | The primary endpoint is grade II-IV acute GVHD | One year | No | |
Secondary | Relapse-free survival | 2 years | No | |
Secondary | Survival | 2 years | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01952184 -
Oocyte Survival After Vitrification in an Open or Closed Device With Closed Storage.
|
N/A | |
Recruiting |
NCT04808466 -
Comparative Study of Lobaplatin and Paclitaxel in Advanced Gastric Cancer Patients With D2 Surgery Combined With Hyperthermic Intraperitoneal Chemotherapy
|
Phase 2 | |
Not yet recruiting |
NCT04845490 -
Comparative Study of Mitomycin and Lobaplatin in Advanced Colorectal Cancer Patients With Radical Surgery Combined With Hyperthermic Intraperitoneal Chemotherapy
|
Phase 2 | |
Recruiting |
NCT03291275 -
Survival Outcomes of Uterine Malignancies in Chinese Population
|
N/A | |
Recruiting |
NCT05720858 -
Telerehabilitation in Survival Breast Cancer Patients
|
N/A | |
Completed |
NCT03351920 -
Ventilation's Parameters Applied in Emergency Medicine. A Prospective Observational Study
|
||
Not yet recruiting |
NCT06147180 -
Comparison of Long-term Survival and Quality of Life After Minimally Invasive Esophagectomy Versus Open Esophagectomy
|
||
Recruiting |
NCT04472403 -
Platinum Plus Low-dose Long-term Continuous Intravenous Infused 5-Fluorouracil in Metastatic Nasopharyngeal Carcinoma
|
||
Recruiting |
NCT03739944 -
Different Surgical Approaches in Patients of Early-stage Cervical Cancer
|
Phase 3 | |
Not yet recruiting |
NCT02960061 -
Perioperative Chemotherapy Combined With HIPEC for High-risk Advanced Gastric Cancer
|
Phase 3 | |
Recruiting |
NCT03738969 -
Longitudinal Study of Different Surgical Approaches in Chinese Patients of Uterine Cervical Cancer
|
||
Completed |
NCT03134807 -
The Very Old Intensive Care Patient: A Multinational Prospective Observation Study
|
||
Completed |
NCT03084809 -
Chemotherapy Combined With CIK Treating Colon Cancer
|
Phase 4 | |
Completed |
NCT03642041 -
Study of Smoking Trajectory in Newly Diagnosis Lung Cancer Patients
|
||
Recruiting |
NCT04351308 -
Comparison of MAPI+Camrelizumab Versus API+Apatinib Versus MAPI in Patients With a Poor Response to Preoperative Chemotherapy for Newly Diagnosed High-grade Osteosarcoma
|
Phase 2 | |
Recruiting |
NCT03920033 -
Salvage Hypofractionated Accelerated Versus Standard Radiotherapy for Biochemical Failure After Prostatectomy
|
N/A | |
Recruiting |
NCT05540119 -
Swedish Oesophago-Gastric Study
|
||
Completed |
NCT04519450 -
Ultrasound of Accessory Respiratory Muscles
|
||
Active, not recruiting |
NCT01835821 -
Clinical Study of Porcelain-fused and IPS e.Max CAD Crowns
|
N/A | |
Completed |
NCT00565188 -
Application of ATP Infusions in Palliative Home Care
|
Phase 3 |